← Leaderboards
Alessandra I Franco
La Jolla Inst For Allergy &Immunolgy
$2,605,073
Attributed
$3,346,332
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $437K · FY2010–21$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,346,332 · 3
By mechanism
R01$2,791,333 · 2
R29$554,999 · 1
Top collaborators
- Jane C Burns4 shared
Most similar at La Jolla Inst For Allergy &Immunolgy
Same institution · by research overlap
- Ping X Lawton$106,372
- Barbara A Sullivan$141,700
Others in their field
Top investigators on “Infusion Procedures”
- Myron S Cohen · Family Health International$91,263,426
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Georgia D Tomaras · Fred Hutchinson Cancer Center$70,233,271
- Dan H. Barouch · Fred Hutchinson Cancer Center$63,804,365
- Lawrence Corey · Fred Hutchinson Cancer Center$58,962,452
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,962,452
Research focus
Infusion ProceduresMucocutaneous Lymph Node SyndromeDoseInflammatory ResponseIntravenous ImmunoglobulinsMolecularCoronary ArteryDeveloped CountriesImmune SystemInflammatoryAntigen PresentationAcuteLeftLifeChildChildhoodDendritic CellsDesignHarvestHeart DiseasesAneurysmInflammationBlood SpecimenPathogenesis
Grant awards (10)
How immunodominant Fc peptide epitopes expand natural regulatory T cells and downregulate inflammation$436,964
R01 · FY2021 · AI · contact PI
How immunodominant Fc peptide epitopes expand natural regulatory T cells and downregulate inflammation$436,272
R01 · FY2020 · AI · contact PI
How immunodominant Fc peptide epitopes expand natural regulatory T cells and downregulate inflammation$435,579
R01 · FY2019 · AI · contact PI
Impact of TNFa blockade on immune function in acute Kawasaki disease$327,630
R01 · FY2013 · HL · contact PI
Impact of TNFa blockade on immune function in acute Kawasaki disease$382,388
R01 · FY2012 · HL · contact PI
Impact of TNFa blockade on immune function in acute Kawasaki disease$386,250
R01 · FY2011 · HL · contact PI
Impact of TNFa blockade on immune function in acute Kawasaki disease$386,250
R01 · FY2010 · HL · contact PI
GENERATION OF THOMSEN-FREIDENREICH-SPECIFIC T CELLS$187,999
R29 · FY2002 · CA
GENERATION OF THOMSEN-FREIDENREICH-SPECIFIC T CELLS$188,000
R29 · FY2001 · CA
GENERATION OF THOMSEN-FREIDENREICH-SPECIFIC T CELLS$179,000
R29 · FY2000 · CA